CMT
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| The Safety and Tolerability of Engensis (VM202) in Patients With Charcot-Marie-Tooth Disease Subtype 1A (CMT1A) (NCT05361031) | Helixmith Co., Ltd. | 2020-09-21 |
| Analysis of Pain and Quality of Life in Patients With Charcot-Marie-Tooth Neuropathy (CMT) (NCT03966287) | University Medical Center Goettingen | 2019-06-03 |
| LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies (NCT02699190) | Children's Hospital of Philadelphia | 2017-01-06 |
| The Myelin Disorders Biorepository Project (NCT03047369) | Children's Hospital of Philadelphia | 2016-12-08 |
Track CMT automatically
Every clearance here is in the API, with alerts when new ones post.